我要投票 百灵鸟在中草药行业中的票数:289
· 外 推 电 报 ·
2025-02-05 18:55:49 星期三

【百灵鸟是哪个国家的品牌?】

百灵鸟是什么牌子?「百灵鸟」是 贵州百灵企业集团制药股份有限公司 旗下著名品牌。该品牌发源于贵州,由创始人姜伟在1999期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

贵州百灵企业集团于2005年5月组建,现有总资产28亿元。其核心企业(母公司)是贵州百灵企业集团制药股份有限公司(深交所002424),成员包括:贵州百灵企业集团天台山药业有限公司、贵州百灵企业集团医药销售有限公司、贵州百灵企业集团纯净水有限公司、贵州百灵企业集团乾元制药有限公司、贵州百灵企业集团千禧制药有限公司,河北德信润生制药有限公司。
2010年,贵州百灵实现主营业务收入8.67亿元,上缴各项税金1.6亿元,总资产28亿元,员工2100余人。
特色就是品牌内涵,特色就是核心竞争力。贵州百灵立足产品的民族化特色,博采民族医药之众长,以科技创新深度研发为突破,走产业化、规模化的品牌发展道路,现已形成“百灵鸟”牌咳速停糖浆(及胶囊)、银丹心脑通软胶囊、维C银翘片、金感胶囊为主导的强势产品架构,涵盖片剂、胶囊剂、糖浆剂等12种生产剂型,107个药品生产批文,多样化、可持续化的品牌体系日臻完善。贵州百灵的产品经多年医学临床运用,其疗效确切、安全、优质、平价等特点为广大患者、业界、市场广泛认同和赞誉。贵州百灵现已成为国内苗药龙头企业之一。
2010年2月26日,中国证监会发审委审核通过了贵州百灵的上市首发申请,并于6月3日在深圳证券交易所正式挂牌上市。贵州百灵在历经两年半的努力后取得这一重大突破,为贵州百灵借助资本市场的强大动力加快发展奠定了坚实的基础。
用心经营健康、用爱回报社会。多年来,贵州百灵积极履行各项社会责任,为社会各界捐款捐物2000余万元。关注健康、服务社会的企业精神深入人心,集成企业发展的巨大内在动力。
贵州百灵长期致力于宣传贵州,以弘扬民族医药事业为己任,积极寻求企业文化创建的方式和载体,出资赞助贵州百灵围棋队、贵州百灵拉力赛车队、贵州百灵少年围棋队,通过参与多项全国赛事,先后取得全国围棋团体赛冠军、全国汽车拉力锦标赛总冠军等多项殊荣。
壁立千仞造就高贵品质,海纳百川始成大家气象。让特色更特,让优势更优,让深度更深,是贵州百灵追求不断超越的灵魂。面对未来,千帆竞渡百舸争流,在新的竞争平台上贵州百灵清醒地认识自己,不断努力进取、开拓创新,以更加积极向上的姿态向全国民族药主导企业的目标奋力前进。

英文翻译:Guizhou bailing enterprise group was established in May 2005 with total assets of 2.8 billion yuan. Its core enterprise (parent company) is Guizhou bailing Group Pharmaceutical Co., Ltd. (Shenzhen Stock Exchange 002424). Its members include: Guizhou bailing group Tiantaishan Pharmaceutical Co., Ltd., Guizhou bailing Group Pharmaceutical Sales Co., Ltd., Guizhou bailing group pure water Co., Ltd., Guizhou bailing group Qianyuan Pharmaceutical Co., Ltd. and Guizhou bailing group Millennium system Pharmaceutical Co., Ltd., Hebei Dexin Runsheng Pharmaceutical Co., Ltd. In 2010, Guizhou bailing achieved a main business income of 867 million yuan, taxes of 160 million yuan, total assets of 2.8 billion yuan, and more than 2100 employees. Characteristic is the connotation of brand, and characteristic is the core competitiveness. Guizhou bailing, based on the national characteristics of its products, has taken the advantages of national medicine, made a breakthrough in scientific and technological innovation and developed its brand in an industrialized and large-scale way. Now it has formed a strong product structure dominated by "bailingniao" brand keshiding syrup (and capsule), Yindanxinnaotong soft capsule, Weic Yinqiao tablet and Jingan capsule, covering tablet, capsule and syrup With 12 kinds of production dosage forms and 107 drug production approvals, the diversified and sustainable brand system is becoming more and more perfect. Guizhou bailing's products have been used in clinical medicine for many years, and its efficacy is accurate, safe, high-quality, affordable and other characteristics are widely recognized and praised by patients, industry and market. Guizhou bailing has become one of the leading seedling medicine enterprises in China. On February 26, 2010, the development and Audit Committee of CSRC approved the IPO application of Guizhou bailing, and it was officially listed on Shenzhen Stock Exchange on June 3. After two and a half years of efforts, Guizhou bailing has made this major breakthrough, which has laid a solid foundation for Guizhou bailing to speed up its development with the help of the powerful power of the capital market. Manage health with heart and repay society with love. Over the years, Guizhou bailing has actively fulfilled various social responsibilities and donated more than 20 million yuan to all sectors of society. The enterprise spirit of paying attention to health and serving the society is deeply rooted in the people's mind, integrating the huge internal power of enterprise development. Guizhou bailing has been committed to promoting Guizhou for a long time, taking the promotion of national medicine as its own duty, actively seeking the way and carrier of corporate culture creation, funding and sponsoring Guizhou bailing go team, Guizhou bailing Rally Team, Guizhou bailing juvenile go team. Through participating in a number of national events, Guizhou Bailing has successively won the national go team championship, the national automobile rally championship championship and many other titles Honor. The noble quality is created by standing on the wall and embracing all rivers. It is the soul that Guizhou bailing pursues to surpass constantly to make its features more special, advantages better and depth deeper. In the face of the future, Qianfan is competing for the best. On the new competition platform, Guizhou bailing has a clear understanding of itself, and constantly strives to forge ahead, develop and innovate, so as to strive forward to the goal of leading national medicine enterprises with a more positive attitude.

本文链接: https://www.waitui.com/brand/2d716e852.html 联系电话:0851-33411018

千城特选小程序码

7×24h 快讯

慈星股份:终止筹划购买武汉敏声控股权并配套募资事项,股票明起复牌

36氪获悉,慈星股份公告,公司因筹划发行股份及支付现金购买武汉敏声新技术有限公司控股权并募集配套资金事项,公司股票自2025年1月15日开市时起开始停牌。经交易相关方商讨研究决定终止筹划本次交易事项,公司股票将于2025年2月6日(星期四)开市起复牌。 截至公告日,交易各方未就本次交易具体方案、交易条件达成最终实质性协议。

56分钟前

汇丰控股:昨日耗资约1.76亿港元回购219.76万股公司股份

36氪获悉,汇丰控股公告,公司于2月4日耗资约1.76亿港元回购219.76万股公司股份,每股回购价格79.6港元-80.45港元。

56分钟前

印尼网约车巨头GoTo否认与Grab合并传闻

印尼网约车巨头GoTo当地时间2月4日提交文件,否认同竞争对手Grab的合并传闻。该公司称,“除实施股票回购外,未来12个月内没有任何重大行动计划”。此前有市场消息称,Grab与GoTo最近几周加快协商,认为今年是达成交易的有利时机。两家公司上市后均逐渐朝向取得盈利迈进,但竞争激烈导致价格无法调涨,同时挤压利润空间。据报道,过去几年双方一直在断断续续地协商,合并障碍包括双方之间的分歧,以及两家公司在印尼、新加坡等市场主导地位可能带来的反垄断问题。(界面)

56分钟前

众鑫股份:泰国工厂一车间正式投产,预计2025年完成产量3万吨以上

36氪获悉,众鑫股份公告,公司泰国工厂一车间已顺利安装完毕,并于2025年1月8号开始调试设备并试机生产,2月1日顺利完成试机并正式投产。同时,二车间开始安装设备。公司预计2025年完成产量3万吨以上,2026年完成产量5万吨。此外,公司将根据国际市场的变化情况,决策是否对泰国工厂实施扩产计划。本次试机成功为公司拓展海外业务打下了基础,也验证了新装备的先进性,为今后的装备研发与升级提供了宝贵经验。

56分钟前

杭州银行:2024年净利润169.83亿元,同比增长18.08%

36氪获悉, 杭州银行发布业绩快报,2024年度实现营业收入383.81亿元,同比增长9.61%;归属于上市公司股东的净利润169.83亿元,同比增长18.08%。截至2024年末,公司总资产21125.91亿元,较上年末增长14.73%;贷款总额9374.99亿元,较上年末增长16.16%;存款总额12725.51亿元,较上年末增长21.74%。

56分钟前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询